Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 5:05 AM
Ignite Modification Date: 2025-12-26 @ 4:08 AM
NCT ID: NCT00987727
Description: The safety population included all subjects who were randomized and treated with at least one dose of the study product. (Note: 3 randomized subjects in the VISMED® Multi group did not receive a dose and were not included in the safety population).
Frequency Threshold: 5
Time Frame: None
Study: NCT00987727
Study Brief: Safety and Efficacy of Carboxymethylcellulose for Ocular Surface Integrity in Symptomatic Dry Eye
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Carboxymethylcellulose 0.5% and Glycerin 0.9% (OPTIVE® MD) carboxymethylcellulose 0.5% and glycerin 0.9% (OPTIVE® MD) None None 1 41 0 41 View
Sodium Hyaluronate 0.18% (VISMED® Multi) sodium hyaluronate 0.18% (VISMED® Multi) None None 1 38 0 38 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Upper Limb Fracture SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA (12.1) View
Amyotrophic Lateral Sclerosis SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (12.1) View
Other Events(If Any):